Intraoperative Imaging Market

Intraoperative Imaging Market by Product (Mobile C-arms, CT, Intraoperative MRI, Ultrasound, X ray), Application (Neurosurgery, Orthopedic & Trauma Care, Spine, CVDs, ENT, Gastroenterology), Enduser (Hospitals, ASCs, Academia)- Forecasts to 2025

Report Code: MD 3582 Feb, 2021, by marketsandmarkets.com

[163 Pages Report] The global intraoperative imaging market size is projected to reach USD 2.5 billion by 2025 from USD 1.9 billion in 2020, at a CAGR of 5.2% during the forecast period. The global intraoperative imaging market offers significant growth potential for prominent as well as emerging product manufacturers. Technological advancements, rising incidence of surgeries and increased funding and public-private investments are some of the key factors driving the growth of the intraoperative imaging market.

Intraoperative Imaging Market

To know about the assumptions considered for the study, download the pdf brochure

COVID-19 Impact on the global intraoperative imaging market

The COVID-19 pandemic has significantly affected the intraoperative imaging market. The market is facing challenges in the manufacturing and supply chain, such as delivering products to end users in a timely manner as well as attending to an uneven demand for the products and services in the sector. In addition, a dearth of skilled lab professionals to conduct/study diagnostic tests, limited operations in most of the industries, inadequate funding for research and academic institutes, temporary closure of major academic institutes, disrupted supply chain, and challenges in providing essential/post-sales services due to lockdowns have led to the reduced supply of intraoperative imaging products to end users. The pandemic has adversely impacted organ donation and transplantation in countries that have experienced high rates of infection, including the US, France, and the UK, all reporting >50% reductions in transplant activity. Australia has experienced a significantly lower incidence of COVID-19. Thus, the pandemic is not estimated to have long-term effects on the fundamental growth drivers or end users in the intraoperative imaging market.

Intraoperative Imaging  Market Dynamics

Driver: Technological advancements in intraoperative imaging modalities

Over the past decade, the medical device sector has witnessed significant transformations and technological advancements in intraoperative imaging, including the emergence of focused imaging technologies and portable/handheld/smartphone-based intraoperative imaging devices. Technologically advanced intraoperative imaging systems offer faster results, higher image quality, easier operations, and simplified consoles as compared to traditional imaging devices.

The key players in the intraoperative imaging market are increasingly focusing on launching novel technologically advanced products. Innovation in this market focuses on developing economical, technologically advanced, and easy-to-use intraoperative imaging systems. An important technological advancement is a reduction in the noise/sound produced by intraoperative imaging systems. Key players have continually produced devices that produce far less sound. Such advancements focus on improving the functionality of intraoperative imaging systems and on expanding their application areas, thereby driving the demand for these systems among end users

Restraint: High cost of intraoperative imaging systems

Intraoperative imaging systems are priced at a premium and require high investments for installations, increasing the procedural cost for patients. This affects the adoption rate of new systems, especially in emerging countries; most healthcare facilities in these countries, consequently, cannot afford such systems.

Healthcare facilities that purchase such costly systems often depend on third-party payers (such as Medicare, Medicaid, or private health insurance plans) to reimburse costs incurred in screening and therapeutic procedures performed using these systems. As a result, factors such as continuous cuts in reimbursements for intraoperative imaging scans and the increasing cost of intraoperative imaging systems prevent medium-sized and small healthcare facilities from investing in advanced intraoperative imaging modalities.

Opportunity: High growth opportunities in emerging countries

Developing economies such as India, China, Brazil, South Korea, Turkey, Russia, and South Africa offer high growth opportunities for the major players in the intraoperative imaging market. Although the cost factor is a concern in these developing countries, their huge population base—especially in India and China—indicates a sustainable market for intraoperative imaging devices.

The higher incidence of chronic diseases such as cancer, stroke, and neUrological Surgery and cardiovascular diseases, as well as the higher death rates in these countries, showcase the need for early detection. For instance, GLOBOCAN 2018 data estimated that roughly over 50% of the global cancer population lived in developing regions. In addition, regulatory policies are more adaptive and business-friendly in the Asia Pacific than in western countries. Increasing competition in mature markets is expected to compel intraoperative imaging system manufacturers to focus on emerging markets.

Challenge: Hospital budget cuts

In response to increasing government pressure to reduce healthcare costs, several healthcare providers have aligned themselves with group purchasing organizations (GPOs), integrated health networks (IHNs), and integrated delivery networks (IDNs). These organizations aggregate their members’ purchases and bargain for a competitive price with the suppliers and manufacturers of medical devices. GPOs, IHNs, and IDNs negotiate heavily for the bulk purchases of intraoperative imaging devices. The rising cost of prescription drugs and a sharp decline in the proposed budget allocations for Health and Human Services in the US, as of 2019, have significantly reduced hospital budgets. A study by the American Hospital Association estimated that federal payment cuts to hospitals would amount to USD 218 billion by 2028, forcing hospitals to allocate smaller budgets annually.

Intraoperative Imaging Market  by Region1

By product, mobile c arm segment is expected to have the largest market share during the forecast period

Mobile C-arms are medical imaging devices that comprise a generator, the X-ray source, and an image intensifier or flat-panel detector. The X-rays emitted by the generator penetrate the patient’s body and are then converted into visible images by the image intensifiers or detectors before being displayed on the monitor. The growing demand for mobile C-arms is mainly attributed to their broadening application horizons. For instance, C-arms are used for a wide range of applications, including cardiovascular surgeries, neurosurgeries, gastroenterology surgeries, orthopedics, traumatology, and urology disorders.

Neurosurgery is the largest application segment of the intraoperative imaging market

The growing demand for intraoperative imaging solutions in neurosurgery is mainly attributed to the increasing adoption of intraoperative imaging products among medical professionals, owing to its technological advancements and rising awareness of intraoperative techniques. For instance, C-arms with high resolution and penetration are essential in monitoring the positioning of screws, instruments, implants, and the injected cement. Furthermore, 3D imaging with navigation enhances treatment precision and enables the intraoperative evaluation of surgical procedures. The use of C-arms for neurosurgery, especially spinal surgeries, is expected to increase in the coming years on account of technological advancements that have made diagnosing and treating issues easier than before.

Hospitals & Diagnostic centers accounted for the largest share of the intraoperative imaging market, by end users, in 2020

Hospitals routinely conduct a wide range of surgical procedures, and most of these surgeries are performed in hospital in-patient settings. Growth in this segment is primarily attributed to the growing number of minimally invasive surgeries and electrosurgery procedures performed in hospitals and the adoption of robotic surgery. The adoption of intraoperative imaging instruments is higher in hospitals, owing to their higher purchasing power and larger volume of surgeries performed. The rising incidence of road accidents, fall-related injuries, and sports injuries has resulted in an increasing number of orthopedic surgeries performed in hospitals; by adding to the procedural volume, the growing incidence of ailments requiring surgical treatment supports the use of intraoperative imaging devices.

Intraoperative Imaging Market  by Region

North America is the largest regional market for Intraoperative imaging

North America (comprising the US and Canada) dominates the intraoperative imaing market. North America is a mature market, with high penetration of intraoperative imaging technologies among key end users  and well-established distribution channels for intraoperative imaging product manufacturers and suppliers. Easy accessibility to and the high adoption of advanced technologies due to the significant per capita annual healthcare expenditure by the US and Canadian governments, as well as supportive government regulations, are driving the growth of the intraoperative imaging market in this region.

Key Market Players

General Electric Company (US), Siemens Healthineers AG (Germany), Ziehm Imaging GmbH (Germany), Medtronic (Ireland), and Koninklijke Philips N.V. (Netherlands) were the top five players in the global intraoperative imaging market. Other notable companies are Canon Healthcare (Japan), Stryker (US), Brainlab AG (Germany), IMRIS (US), Shimadzu Corporation (Japan), Shenzhen Anke High-tech Co. (China), Hitachi, Ltd. (Japan), FUJIFILM Holdings (Japan), Carl Zeiss Meditec AG (Germany), Mindray Ltd. (US), Carestream Health (US), Analogic Corporation (US), Allengers Medical Systems Ltd. (India), Esaote SpA (Italy) and NeuroLogica Corporation (US).

GE Healthcare (US): The company is a key business division of General Electric Company, which is among the top players engaged in the development and manufacturing of intraoperative imaging devices. The company focuses on maintaining its leadership position in the intraoperative imaging market through pipeline development and product commercialization. The company commercialized several key products from 2017 to 2020. It has also strengthened its customer base and increased its market penetration in major intraoperative imaging markets such as the US, Europe, Asia, and Africa.

Scope of the report

Report Metric

Details

Market Size Available for Years

2018–2025

Base Year Considered

2020

Forecast Period

2020–2025

Forecast Units

Value (USD Billion)

Segments Covered

Product, Application, End Users and Region

Geographies Covered

North America (US & Canada), Europe (Germany, the UK, France, Italy, Spain, and RoE), APAC (Japan, China, India, and the RoAPAC), LATAM (Brazil, Mexico, and RoLATAM), and MEA

Companies Covered

General Electric Company (US), Siemens Healthineers AG (Germany), Ziehm Imaging GmbH (Germany), Medtronic (Ireland), and Koninklijke Philips N.V. (Netherlands) were the top five players in the global intraoperative imaging market. Other notable companies are Canon Healthcare (Japan), Stryker (US), Brainlab AG (Germany), IMRIS (US), Shimadzu Corporation (Japan), Shenzhen Anke High-tech Co. (China), Hitachi, Ltd. (Japan), FUJIFILM Holdings (Japan), Carl Zeiss Meditec AG (Germany), Mindray Ltd. (US), Carestream Health (US), Analogic Corporation (US), Allengers Medical Systems Ltd. (India), Esaote SpA (Italy) and NeuroLogica Corporation (US)

This research report categorizes the intraoperative imaging market based on product, application, usabilty, end user, and region.

By Product

  • Mobile C Arm
  • Ultrasound
    • Laparoscopic probes
    • Drop-in probes
    • Other devices
  • CT
  • MRI
  • X Rays
  • Intraoperative optical imaging

By Application

  • Neurosurgery
  • Orthopedic & Trauma Surgery
  • Spine Surgery
  • Cardiovascular Surgery
  • ENT Surgery
  • Oncology
  • Emergency & Trauma Surgery
  • Urological
  • HPB surgery
  • Colorectal
  • General Surgery
  • Other Applications

By End Users

  • Hospitals & Diagnostic Centers
  • Ambulatory Surgical Centers and Clinics
  • Research Laboratories & Academic Institutes

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • RoE
  • Asia Pacific
    • Japan
    • China
    • India
    • RoAPAC
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa

Recent Developments

  • In 2019, Canon Medical (Japan) launched Global Illumination next-generation rendering capabilities to allow clinicians to visualize and manipulate photo-realistic anatomical images
  • In 2019, Seimens AG (Germany) established a new R&D center in Bengaluru, India, which offers diagnostic imaging solutions and advanced therapies. The center will manufacture mobile C-arm devices locally in India.
  • In 2019, IMRIS, Deerfield Imaging announced a collaboration with the Prince Sultan Military Medical City and distributor Gulf Medical Company to install the first IMRIS Surgical Theatre in Saudi Arabia.
  • In 2018, Koninklijke Philips N.V. (Netherlands) established an AI lab in Shanghai, China. The AI lab is dedicated to driving the integration of AI technologies in medical imaging, image-guided therapies, patient monitoring, health informatics, home care, and personal health applications.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 20)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
           1.2.1 MARKET SCOPE
           FIGURE 1 MARKETS COVERED
           1.2.2 GEOGRAPHIC SCOPE
           1.2.3 YEARS CONSIDERED FOR THE STUDY
    1.3 CURRENCY USED FOR THE STUDY
    1.4 MAJOR MARKET STAKEHOLDERS
    1.5 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 24)
    2.1 RESEARCH DATA
           FIGURE 2 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
                    2.1.1.1 Secondary sources
           2.1.2 PRIMARY DATA
           FIGURE 3 BREAKDOWN OF PRIMARIES: INTRAOPERATIVE IMAGING MARKET
    2.2 MARKET ESTIMATION METHODOLOGY
           FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
           2.2.1 END USER -BASED MARKET ESTIMATION
           2.2.2 REVENUE MAPPING-BASED MARKET ESTIMATION
           FIGURE 5 MARKET SIZE ESTIMATION: INTRAOPERATIVE IMAGING MARKET
           2.2.3 PRIMARY RESEARCH VALIDATION
    2.3 DATA TRIANGULATION
           FIGURE 6 DATA TRIANGULATION METHODOLOGY
    2.4 RESEARCH ASSUMPTIONS
    2.5 RESEARCH LIMITATIONS

3 EXECUTIVE SUMMARY (Page No. - 32)
           FIGURE 7 INTRAOPERATIVE IMAGING MARKET, BY PRODUCT, 2020 VS. 2025 (USD MILLION)
           FIGURE 8 INTRAOPERATIVE IMAGING MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION)
           FIGURE 9 INTRAOPERATIVE IMAGING MARKET, BY END USER, 2020 VS. 2025 (USD MILLION)
           FIGURE 10 ASIA PACIFIC MARKET TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD

4 PREMIUM INSIGHTS (Page No. - 35)
    4.1 INTRAOPERATIVE IMAGING MARKET OVERVIEW
           FIGURE 11 INCREASING PREVALENCE OF TARGET DISEASES TO DRIVE MARKET GROWTH
    4.2 INTRAOPERATIVE IMAGING MARKET, BY PRODUCT
           FIGURE 12 MOBILE C-ARMS TO ACCOUNT FOR THE LARGEST SHARE OF THE MARKET DURING THE FORECAST PERIOD
    4.3 APAC: INTRAOPERATIVE IMAGING MARKET, BY COUNTRY AND PRODUCT
           FIGURE 13 JAPAN IS THE LARGEST MARKET FOR INTRAOPERATIVE IMAGING IN APAC
    4.4 INTRAOPERATIVE IMAGING MARKET SHARE, BY END USER
           FIGURE 14 HOSPITALS & DIAGNOSTIC CENTERS TO ACCOUNT FOR THE LARGEST MARKET SHARE DURING THE FORECAST PERIOD
    4.5 GEOGRAPHICAL SNAPSHOT OF THE INTRAOPERATIVE IMAGING MARKET
           FIGURE 15 CHINA TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD

5 MARKET OVERVIEW (Page No. - 39)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
           FIGURE 16 INTRAOPERATIVE IMAGING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.2.1 DRIVERS
                    5.2.1.1 Rising geriatric population and growth in the prevalence of chronic diseases
           TABLE 1 AGE-RELATED DISEASES: PREVALENCE AND ESTIMATIONS
                    5.2.1.2 Technological advancements in intraoperative imaging modalities
                    5.2.1.3 Increasing demand for minimally invasive surgeries
                    5.2.1.4 Rising investments/funds/grants by public-private organizations
           TABLE 2 KEY INVESTMENTS BY GOVERNMENT BODIES IN THE INTRAOPERATIVE IMAGING MARKET
           5.2.2 RESTRAINTS
                    5.2.2.1 High cost of intraoperative imaging systems
                    5.2.2.2 Declining reimbursements and increasing regulatory burden
           5.2.3 OPPORTUNITIES
                    5.2.3.1 High growth opportunities in emerging countries
                    5.2.3.2 Adoption of AI and analytics in intraoperative imaging
           5.2.4 CHALLENGES
                    5.2.4.1 Hospital budget cuts
                    5.2.4.2 Dearth of trained professionals
                    5.2.4.3 Increasing adoption of refurbished systems
    5.3 REGULATORY SCENARIO
    5.4 ECOSYSTEM COVERAGE
    5.5 VALUE CHAIN ANALYSIS
    5.6 PRICING ANALYSIS
           TABLE 3 INTRAOPERATIVE IMAGING PRODUCTS PRICING ANALYSIS (USD, 2019)
    5.7 PORTER’S 5 FORCE ANALYSIS

6 INTRAOPERATIVE IMAGING MARKET, BY PRODUCT (Page No. - 49)
    6.1 INTRODUCTION
           TABLE 4 INTRAOPERATIVE IMAGING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
    6.2 MOBILE C-ARMS
           6.2.1 MULTI-FUNCTIONAL CAPABILITIES OF C-ARMS WILL INCREASE THEIR ADOPTION AMONG SURGEONS
           TABLE 5 PRODUCT HIGHLIGHTS
           TABLE 6 INTRAOPERATIVE IMAGING MARKET FOR MOBILE C-ARMS, BY REGION, 2018–2025 (USD MILLION)
           TABLE 7 INTRAOPERATIVE IMAGING MARKET FOR MOBILE C-ARMS, BY APPLICATION, 2018–2025 (USD MILLION)
           TABLE 8 INTRAOPERATIVE IMAGING MARKET FOR MOBILE C-ARMS, BY END USER, 2018–2025 (USD MILLION)
    6.3 ULTRASOUND SYSTEMS
           6.3.1 DIAGNOSTIC SUPERIORITY AND GROWING APPLICATIONS WILL INCREASE THE ADOPTION OF INTRAOPERATIVE ULTRASOUND
           TABLE 9 INTRAOPERATIVE IMAGING MARKET FOR ULTRASOUND SYSTEMS, BY PRODUCT, 2018–2025 (USD MILLION)
           TABLE 10 INTRAOPERATIVE IMAGING MARKET FOR ULTRASOUND SYSTEMS, BY REGION, 2018–2025 (USD MILLION)
           TABLE 11 INTRAOPERATIVE IMAGING MARKET FOR ULTRASOUND SYSTEMS, BY APPLICATION, 2018–2025 (USD MILLION)
           TABLE 12 INTRAOPERATIVE IMAGING MARKET FOR ULTRASOUND SYSTEMS, BY END USER, 2018–2025 (USD MILLION) 
           6.3.2 DROP IN PROBES
                    6.3.2.1 Drop in Probes segment will dominate the ultrasound market in upcoming years
           TABLE 13 INTRAOPERATIVE IMAGING MARKET FOR DROP IN PROBES, BY REGION, 2018–2025 (USD MILLION)
           6.3.3 LAPAROSCOPIC PROBES
                    6.3.3.1 Laparoscopic probe utilization is augmented by rising number of related surgical procedures across key geographies.
           TABLE 14 INTRAOPERATIVE IMAGING MARKET FOR LAPAROSCOPIC PROBES, BY REGION, 2018–2025 (USD MILLION)
           6.3.4 OTHER ULTRASOUND SYSTEMS
                    6.3.4.1 Other ultrasound segment market will have smaller segment due to technical difficulties.
           TABLE 15 INTRAOPERATIVE IMAGING MARKET FOR OTHER ULTRASOUND SYSTEMS, BY REGION, 2018–2025 (USD MILLION)
    6.4 CT SCANNERS
           6.4.1 CT USE IN DIAGNOSTIC APPLICATIONS HAS RISEN SIGNIFICANTLY IN RECENT YEARS
           TABLE 16 INTRAOPERATIVE IMAGING MARKET FOR CT SCANNERS, BY REGION, 2018–2025 (USD MILLION)
           TABLE 17 INTRAOPERATIVE IMAGING MARKET FOR CT SCANNERS, BY APPLICATION, 2018–2025 (USD MILLION)
           TABLE 18 INTRAOPERATIVE IMAGING MARKET FOR CT SCANNERS, BY END USER, 2018–2025 (USD MILLION)
    6.5 MRI SCANNERS
           6.5.1 FASTER SCAN TIMES AND INCREASED IMAGE QUALITY TO INCREASE THE ADOPTION OF INTRAOPERATIVE MRI SYSTEMS
           TABLE 19 INTRAOPERATIVE IMAGING MARKET FOR MRI SCANNERS, BY REGION, 2018–2025 (USD MILLION)
           TABLE 20 INTRAOPERATIVE IMAGING MARKET FOR MRI SCANNERS, BY APPLICATION, 2018–2025 (USD MILLION)
           TABLE 21 INTRAOPERATIVE IMAGING MARKET FOR MRI SCANNERS, BY END USER, 2018–2025 (USD MILLION)
    6.6 X-RAY SYSTEMS
           6.6.1 POSSIBILITY OF SIDE-EFFECTS DUE TO RADIATION EXPOSURE MAY HINDER MARKET GROWTH
           TABLE 22 INTRAOPERATIVE IMAGING MARKET FOR X-RAY SYSTEMS, BY REGION, 2018–2025 (USD MILLION)
           TABLE 23 INTRAOPERATIVE IMAGING MARKET FOR X-RAY SYSTEMS, BY APPLICATION, 2018–2025 (USD MILLION)
           TABLE 24 INTRAOPERATIVE IMAGING MARKET FOR X-RAY SYSTEMS, BY END USER, 2018–2025 (USD MILLION)
    6.7 OPTICAL IMAGING SYSTEMS
           6.7.1 GROWING DEMAND FOR NON-IONIZING IMAGING MODALITIES TO AID MARKET GROWTH
           TABLE 25 INTRAOPERATIVE IMAGING MARKET FOR OPTICAL IMAGING SYSTEMS, BY REGION, 2018–2025 (USD MILLION)
           TABLE 26 INTRAOPERATIVE IMAGING MARKET FOR OPTICAL IMAGING SYSTEMS, BY APPLICATION, 2018–2025 (USD MILLION)
           TABLE 27 INTRAOPERATIVE IMAGING MARKET FOR OPTICAL IMAGING SYSTEMS, BY END USER, 2018–2025 (USD MILLION)

7 INTRAOPERATIVE IMAGING MARKET, BY APPLICATION (Page No. - 65)
    7.1 INTRODUCTION
           TABLE 28 INTRAOPERATIVE IMAGING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
    7.2 NEUROSURGERY
           7.2.1 NEUROSURGERY HOLDS THE LARGEST SHARE OF THE APPLICATIONS MARKET
           TABLE 29 INTRAOPERATIVE IMAGING MARKET FOR NEUROSURGERY, BY REGION, 2018–2025 (USD MILLION)
    7.3 CARDIOVASCULAR SURGERY
           7.3.1 INCREASING PREVALENCE OF CARDIOVASCULAR DISEASES TO SUPPORT THE MARKET GROWTH
           TABLE 30 INTRAOPERATIVE IMAGING MARKET FOR CARDIOVASCULAR SURGERY, BY REGION, 2018–2025 (USD MILLION)
    7.4 ORTHOPEDIC SURGERY
           7.4.1 RISING GERIATRIC POPULATION & RISING OBESITY RATES HAVE DRIVEN THE NUMBER OF ORTHOPEDIC SURGERIES PERFORMED
           TABLE 31 INTRAOPERATIVE IMAGING MARKET FOR ORTHOPEDIC SURGERY, BY REGION, 2018–2025 (USD MILLION)
    7.5 SPINE SURGERY
           7.5.1 RISING NUMBER OF SPINE INJURIES AND GROWING ACCESS TO SPINE SURGERY WILL DRIVE MARKET GROWTH
           TABLE 32 INTRAOPERATIVE IMAGING MARKET FOR SPINE SURGERY, BY REGION, 2018–2025 (USD MILLION)
    7.6 SURGICAL ONCOLOGY
           7.6.1 INCREASING PREVALENCE OF CANCER WILL DRIVE THE MARKET GROWTH
           TABLE 33 INTRAOPERATIVE IMAGING MARKET FOR SURGICAL ONCOLOGY, BY REGION, 2018–2025 (USD MILLION)
    7.7 EMERGENCY AND TRAUMA SURGERIES
           7.7.1 EMERGENCY & TRAUMA CENTERS SUPPORTS THE GORWTH OF THIS SEGMENTS
           TABLE 34 INTRAOPERATIVE IMAGING MARKET FOR EMERGENCY SURGERIES, BY REGION, 2018–2025 (USD MILLION)
    7.8 ENT SURGERY
           7.8.1 GROWING FOCUS ON MINIMALLY INVASIVE AND IMAGE-GUIDED SURGERY SHOWCASE STRONG GROWTH POTENTIAL
           TABLE 35 INTRAOPERATIVE IMAGING MARKET FOR ENT SURGERY, BY REGION, 2018–2025 (USD MILLION)
    7.9 UROLOGICAL SURGERY
           7.9.1 GROWING INCIDENCE OF UROLOGICAL CONDITIONS TO AUGMENT POSITIVE GROWTH POTENTIAL OF RELATED SURGICAL PLATFORMS
           TABLE 36 INTRAOPERATIVE IMAGING MARKET FOR UROLOGICAL SURGERY, BY REGION, 2018–2025 (USD MILLION)
    7.10 HBP (HEPATO-PANCREATICO-BILIARY) SURGERY
           7.10.1 GROWING INCIDENCE OF UROLOGICAL SURGERY CONDISTIONS SHOWCASE STRONG GROWTH POTENTIAL
           TABLE 37 INTRAOPERATIVE IMAGING MARKET FOR HPB SURGERY, BY REGION, 2018–2025 (USD MILLION)
    7.11 COLORECTAL SURGERIES
           7.11.1 COLORECTAL SEGMENT IS LIKELY TO GROW AT SLOW GROWTH RATE IN UPCOMING YEAR
           TABLE 38 INTRAOPERATIVE IMAGING MARKET FOR COLORECTAL SURGERIES, BY REGION, 2018–2025 (USD MILLION)
    7.12 GENERAL SURGERY
           7.12.1 INCREASING NUMBER OF BARIATRIC SURGERY TO DRIVE MARKET GROWTH
           TABLE 39 INTRAOPERATIVE IMAGING MARKET FOR GENERAL SURGERIES, BY REGION, 2018–2025 (USD MILLION)
    7.13 OTHER APPLICATIONS
           7.13.1 OTHER APPLICATIONS SEGMENT IS LIKELY TO GROW AT SLOW GROWTH RATE IN UPCOMING YEAR
           TABLE 40 INTRAOPERATIVE IMAGING MARKET FOR OTHER APPLICATIONS, BY REGION, 2018–2025 (USD MILLION)

8 INTRAOPERATIVE IMAGING MARKET, BY END USER (Page No. - 79)
    8.1 INTRODUCTION
           TABLE 41 INTRAOPERATIVE IMAGING MARKET, BY END USER, 2018–2025 (USD MILLION)
    8.2 HOSPITALS & DIAGNOSTIC CENTERS
           8.2.1 INCREASING NUMBER OF SURGERIES AND HIGH PURCHASING POWER TO SUPPORT THE GROWTH OF THIS SEGMENT
           TABLE 42 INTRAOPERATIVE IMAGING MARKET FOR HOSPITALS & DIAGNOSTICS CENTERS, BY REGION, 2018–2025 (USD MILLION)
    8.3 AMBULATORY SURGICAL CENTERS & CLINICS
           8.3.1 INCREASING NUMBER OF ASCS LIKELY TO DRIVE MARKET GROWTH
           TABLE 43 INTRAOPERATIVE IMAGING MARKET FOR AMBULATORY SURGICAL CENTERS & CLINICS, BY REGION, 2018–2025 (USD MILLION)
    8.4 RESEARCH LABORATORIES & ACADEMIC INSTITUTES
           8.4.1 BUDGETARY RESTRICTIONS OF RESEARCHERS ARE LIMITING THE ADOPTION OF HIGH-END INTRAOPERATIVE IMAGING PRODUCTS
           TABLE 44 INTRAOPERATIVE IMAGING MARKET FOR RESEARCH LABORATORIES & ACADEMIC INSTITUTES, BY REGION, 2018–2025 (USD MILLION)

9 INTRAOPERATIVE IMAGING MARKET, BY REGION (Page No. - 84)
    9.1 INTRODUCTION
           TABLE 45 INTRAOPERATIVE IMAGING MARKET, BY REGION, 2018–2025 (USD MILLION)
    9.2 NORTH AMERICA
           FIGURE 17 NORTH AMERICA: INTRAOPERATIVE IMAGING MARKET SNAPSHOT
           TABLE 46 NORTH AMERICA: INTRAOPERATIVE IMAGING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 47 NORTH AMERICA: INTRAOPERATIVE IMAGING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
           TABLE 48 NORTH AMERICA: INTRAOPERATIVE IMAGING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
           TABLE 49 NORTH AMERICA: INTRAOPERATIVE IMAGING MARKET, BY END USER, 2018–2025 (USD MILLION)
           9.2.1 US
                    9.2.1.1 The US dominates the North American market
           TABLE 50 INCREASE IN TARGET POPULATION/DISEASE PREVALENCE IN THE US
           TABLE 51 US: INTRAOPERATIVE IMAGING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
           9.2.2 CANADA
                    9.2.2.1 A dearth of radiologists and long waiting times restrain market growth in Canada
           TABLE 52 INCREASE IN TARGET POPULATION/DISEASE PREVALENCE IN CANADA
           TABLE 53 CANADA: INTRAOPERATIVE IMAGING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
    9.3 EUROPE
           TABLE 54 EUROPE: INTRAOPERATIVE IMAGING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 55 EUROPE: INTRAOPERATIVE IMAGING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
           TABLE 56 EUROPE: INTRAOPERATIVE IMAGING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
           TABLE 57 EUROPE: INTRAOPERATIVE IMAGING MARKET, BY END USER, 2018–2025 (USD MILLION)
           9.3.1 GERMANY
                    9.3.1.1 Germany holds the largest share of the market in Europe
           TABLE 58 INCREASE IN TARGET POPULATION/DISEASE PREVALENCE IN GERMANY
           TABLE 59 GERMANY: INTRAOPERATIVE IMAGING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
           9.3.2 UK
                    9.3.2.1 Government initiatives to support market growth in the UK
           TABLE 60 UK: INTRAOPERATIVE IMAGING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
           9.3.3 FRANCE
                    9.3.3.1 Availability of funding, strong player presence, and government support are key drivers in France
           TABLE 61 FRANCE: INTRAOPERATIVE IMAGING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
           9.3.4 ITALY
                    9.3.4.1 Favorable regulatory policies likely to support market growth
           TABLE 62 ITALY: INTRAOPERATIVE IMAGING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
           9.3.5 SPAIN
                    9.3.5.1 Preference for new equipment likely to increase the market growth
           TABLE 63 SPAIN: INTRAOPERATIVE IMAGING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
           9.3.6 REST OF EUROPE
           TABLE 64 ROE: INTRAOPERATIVE IMAGING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
    9.4 ASIA PACIFIC
           FIGURE 18 ASIA PACIFIC: INTRAOPERATIVE IMAGING MARKET SNAPSHOT
           TABLE 65 APAC: INTRAOPERATIVE IMAGING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 66 APAC: INTRAOPERATIVE IMAGING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
           TABLE 67 APAC: INTRAOPERATIVE IMAGING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
           TABLE 68 APAC: INTRAOPERATIVE IMAGING MARKET, BY END USER, 2018–2025 (USD MILLION)
           9.4.1 JAPAN
                    9.4.1.1 Japan dominates the APAC market
           TABLE 69 JAPAN: INTRAOPERATIVE IMAGING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
           9.4.2 CHINA
                    9.4.2.1 Government initiatives and investments support the growth of the Chinese market
           TABLE 70 CHINA: INTRAOPERATIVE IMAGING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
           9.4.3 INDIA
                    9.4.3.1 Rising disease incidence and growing awareness support market growth; uncertainties in healthcare policies and uneven coverage pose challenges
           TABLE 71 INDIA: INTRAOPERATIVE IMAGING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
           9.4.4 AUSTRALIA
                    9.4.4.1 Support for R&D and equipment purchases drives the market growth in Australia
           TABLE 72 AUSTRALIA: INTRAOPERATIVE IMAGING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
           9.4.5 SOUTH KOREA
                    9.4.5.1 Supportive government initiatives expected to impact market growth positively
           TABLE 73 SOUTH KOREA: INTRAOPERATIVE IMAGING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
           9.4.6 REST OF ASIA PACIFIC
           TABLE 74 ROAPAC: INTRAOPERATIVE IMAGING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
    9.5 LATIN AMERICA
           TABLE 75 LATIN AMERICA: INTRAOPERATIVE IMAGING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 76 LATAM: INTRAOPERATIVE IMAGING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
           TABLE 77 LATAM: INTRAOPERATIVE IMAGING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
           TABLE 78 LATAM: INTRAOPERATIVE IMAGING MARKET, BY END USER, 2018–2025 (USD MILLION)
           9.5.1 BRAZIL
                    9.5.1.1 Growing disease burden and rising awareness to support market growth in Brazil
           TABLE 79 BRAZIL: INTRAOPERATIVE IMAGING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
           9.5.2 MEXICO
                    9.5.2.1 Favorable investment scenario for medical device manufacturers to drive market growth in Mexico
           TABLE 80 MEXICO: INTRAOPERATIVE IMAGING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
           9.5.3 REST OF LATIN AMERICA
           TABLE 81 ROLATAM: INTRAOPERATIVE IMAGING MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 
    9.6 MIDDLE EAST AND AFRICA
           9.6.1 RISING DISPOSABLE INCOME AND INFRASTRUCTURAL DEVELOPMENT TO CONTRIBUTE TO MARKET GROWTH
           TABLE 82 MEA: INTRAOPERATIVE IMAGING MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
           TABLE 83 MEA: INTRAOPERATIVE IMAGING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
           TABLE 84 MEA: INTRAOPERATIVE IMAGING MARKET, BY END USER, 2018–2025 (USD MILLION)

10 COMPETITIVE LANDSCAPE (Page No. - 117)
     10.1 OVERVIEW
           FIGURE 19 KEY DEVELOPMENTS IN THE INTRAOPERATIVE IMAGING MARKET (2017–2020)
     10.2 GLOBAL MARKET SHARE ANALYSIS (2019)
           FIGURE 20 GE HEALTHCARE HELD THE LEADING POSITION IN THE INTRAOPERATIVE IMAGING MARKET IN 2019
     10.3 COMPETITIVE SCENARIO (2017–2020)
             10.3.1 KEY PRODUCT LAUNCHES (2017–2020)
             10.3.2 KEY EXPANSIONS (2017–2020)
             10.3.3 KEY ACQUISITIONS (2017–2020)
             10.3.4 KEY AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS (2017–2020)
     10.4 COMPETITIVE LEADERSHIP MAPPING
     10.5 VENDOR INCLUSION CRITERIA
             10.5.1 STARS
             10.5.2 EMERGING LEADERS
             10.5.3 PERVASIVE PLAYERS
             10.5.4 PARTICIPANTS
           FIGURE 21 INTRAOPERATIVE IMAGING MARKET (GLOBAL) COMPETITIVE LEADERSHIP MAPPING, 2019
     10.6 COMPETITIVE LEADERSHIP MAPPING: EMERGING COMPANIES/SMES/START-UPS (2019)
             10.6.1 PROGRESSIVE COMPANIES
             10.6.2 STARTING BLOCKS
             10.6.3 RESPONSIVE COMPANIES
             10.6.4 DYNAMIC COMPANIES
           FIGURE 22 INTRAOPERATIVE IMAGING MARKET: GLOBAL COMPETITIVE LEADERSHIP MAPPING, 2019 (SME/START-UPS)

11 COMPANY PROFILES (Page No. - 126)
(Business overview, Products offered, Recent developments, MNM view)* 
     11.1 GENERAL ELECTRIC COMPANY
           FIGURE 23 GENERAL ELECTRIC COMPANY: COMPANY SNAPSHOT
     11.2 SIEMENS HEALTHINEERS AG
           FIGURE 24 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT
     11.3 CANON MEDICAL SYSTEMS CORPORATION
           FIGURE 25 CANON MEDICAL SYSTEMS CORPORATION: COMPANY SNAPSHOT
     11.4 MEDTRONIC PLC
           FIGURE 26 MEDTRONIC PLC: COMPANY SNAPSHOT (2019)
     11.5 KONINKLIJKE PHILIPS N.V.
           FIGURE 27 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
     11.6 CARESTREAM HEALTH
     11.7 SHIMADZU CORPORATION
           FIGURE 28 SHIMADZU CORPORATION: COMPANY SNAPSHOT
     11.8 SHENZHEN ANKE HIGH-TECH CO., LTD.
     11.9 BRAINLAB AG
     11.10 ZIEHM IMAGING GMBH
     11.11 HITACHI, LTD.
           FIGURE 29 HITACHI, LTD.: COMPANY SNAPSHOT
     11.12 FUJIFILM HOLDINGS CORPORATION
           FIGURE 30 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT
     11.13 IMRIS, DEERFIELD IMAGING, INC.
     11.14 STRYKER CORPORATION
           FIGURE 31 STRYKER CORPORATION: COMPANY SNAPSHOT (2019)
     11.15 NEUROLOGICA CORPORATION
*Business overview, Products offered, Recent developments, MNM view might not be captured in case of unlisted companies. 
     11.16 OTHER COMPANIES
             11.16.1 ESAOTE SPA
             11.16.2 ANALOGIC CORPORATION
             11.16.3 MINDRAY MEDICAL INTERNATIONAL LIMITED
             11.16.4 CARL ZEISS MEDITEC AG
             11.16.5 ALLENGERS MEDICAL SYSTEMS LTD.

12 APPENDIX (Page No. - 156)
     12.1 DISCUSSION GUIDE
     12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     12.3 AVAILABLE CUSTOMIZATIONS
     12.4 RELATED REPORTS
     12.5 AUTHOR DETAILS

 

The study involved four major activities to estimate the current size of the intraoperative imaging market. Exhaustive secondary research was carried out to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the size of segments and subsegments.

Secondary Research

In the secondary research process, various secondary sources, such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to in order to identify and collect information for the orthopedic braces and supports market study.

Primary Research

The intraoperative imaging market comprises several stakeholders such as Intraoperative imaging product manufacturing companies , Product distributors and channel partners, Hospitals and surgical centers, Orthopedic clinics, Emergency care units and trauma centers, Ambulatory care centers, physician-operated labs, and skilled nursing facilities, Contract manufacturers and third-party suppliers, Research laboratories and academic institutes, Clinical research organizations (CROs), Government and non-governmental regulatory authorities, Market research and consulting firms. The demand side of this market is characterized by the increasing incidence of transplants and technological advancements, and increased funding and public-private investments. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is the breakdown of primary respondents:

Intraoperative Imaging Market  Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the intraoperative imaging market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and markets have been identified through extensive secondary research
  • The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Intraoperative Imaging Market  Size, and Share1

Data Triangulation

After arriving at the overall market size-using the market size estimation processes as explained above-the intraoperative imaging market was split into several segments and subsegments. In order to complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the clinical microbiology industry.

Report Objectives

  • To define, describe, and forecast the intraoperative imaging market by product, application, end user, and region
  • To provide detailed information about the major factors influencing the market growth (such as key drivers, restraints, opportunities, and industry-specific challenges)
  • To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and their contributions to the overall intraoperative imaging market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the revenue of market segments with respect to five major regions, namely,
    North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
  • To profile the key players active in the intraoperative imaging market and comprehensively analyze their global revenue shares and core competencies2
  • To track and analyze competitive market-specific developments such as product launches, collaborations, agreements, partnerships, expansions, and mergers & acquisitions in the intraoperative imaging market

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the intraoperative imaging market report:

Product Analysis

  • Product Matrix, which gives a detailed comparison of the product portfolios of the top five global players

Product Analysis

  • Further breakdown of the Rest of European market into Poland, Nederland and other European countries (aggregated)

Company Information

  • Detailed analysis and profiling of additional market players (up to 5 OEMs)
COVID-19

Get in-depth analysis of the COVID-19 impact on the Intraoperative Imaging Market

Benchmarking the rapid strategy shifts of the Top 100 companies in the Intraoperative Imaging Market

Request For Special Pricing
Report Code
MD 3582
Published ON
Feb, 2021
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Intraoperative Imaging Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2021 MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

Home